The Risk of Relapse in Papillary Thyroid Cancer (PTC) in the Context of BRAF(V600E) Mutation Status and Other Prognostic Factors

INTRODUCTION: The risk of over-treatment in low-advanced PTC stages has prompted clinicians to search for new reliable prognostic factors. The presence of BRAF mutation, the most frequent molecular event in PTC, seems to be a good candidate. However, there is still lack of randomised trials and its...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:PLoS One
Autors principals: Czarniecka, Agnieszka, Kowal, Monika, Rusinek, Dagmara, Krajewska, Jolanta, Jarzab, Michal, Stobiecka, Ewa, Chmielik, Ewa, Zembala-Nozynska, Ewa, Poltorak, Stanislaw, Sacher, Aleksander, Maciejewski, Adam, Zebracka-Gala, Jadwiga, Lange, Dariusz, Oczko-Wojciechowska, Malgorzata, Handkiewicz-Junak, Daria, Jarzab, Barbara
Format: Artigo
Idioma:Inglês
Publicat: Public Library of Science 2015
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4503446/
https://ncbi.nlm.nih.gov/pubmed/26177218
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0132821
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars